Bonci D, Coppola V, Patrizii M, Addario A, Cannistraci A, Francescangeli F, Pecci R, Muto G, Collura D, Bedini R, Zeuner A, Valtieri M, Sentinelli S, Benassi MS, Gallucci M, Carlini P, Piccolo S, De Maria R

A microRNA code for prostate cancer metastasis.

Oncogene 2016; 1180-92. doi: 10.1038/onc.2015.176

Bartucci M, Dattilo R, Moriconi C, Pagliuca A, Mottolese M, Federici G, Benedetto AD, Todaro M, Stassi G, Sperati F, Amabile MI, Pilozzi E, Patrizii M, Biffoni M, Maugeri-Saccà M, Piccolo S, De Maria R

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Oncogene 2015; 681-90. doi: 10.1038/onc.2014.5

Pavani M, Bonaiuti P, Chiroli E, Gross F, Natali F, Macaluso F, Póti Á, Pasqualato S, Farkas Z, Pompei S, Cosentino Lagomarsino M, Rancati G, Szüts D, Ciliberto A

Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerization.

EMBO J 2021; e108225. doi: 10.15252/embj.2021108225

Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, Basso G, Leo G, Rosato A, Bicciato S, Cordenonsi M, Piccolo S

SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors.

Nature 2012; 380-4. doi: 10.1038/nature11207

Turner N, Moretti E, Siclari O, Migliaccio I, Santarpia L, D'Incalci M, Piccolo S, Veronesi A, Zambelli A, Del Sal G, Di Leo A

Targeting triple negative breast cancer: is p53 the answer?

Cancer Treat Rev 2013; 541-50. doi: 10.1016/j.ctrv.2012.12.001

Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E, Stantzou A, Mouisel E, Toniolo L, Ferry A, Stricker S, Goldberg AL, Dupont S, Piccolo S, Amthor H, Sandri M

BMP signaling controls muscle mass.

Nat Genet 2013; 1309-18. doi: 10.1038/ng.2772

%PLACEHOLDER%